NCT06492343View on ClinicalTrials.gov

Neurofeedback in Clinical High Risk

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

August 31, 2028

Study Completion Date

December 31, 2028

Conditions
Real Neurofeedback From DMNSham Neurofeedback From Motor Cortex
Interventions
OTHER

fMRI based neurofeedback

participants will receive neurofeedback from their brain in order to modify their own brain function

All Listed Sponsors
lead

Boston VA Research Institute, Inc.

OTHER

NCT06492343 - Neurofeedback in Clinical High Risk | Biotech Hunter | Biotech Hunter